The potential of pomegranate and its components for prevention and treatment of breast cancer

被引:0
作者
Wang, Lei [1 ]
Martins-Green, Manuela [1 ]
机构
[1] Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA
来源
AGRO FOOD INDUSTRY HI-TECH | 2013年 / 24卷 / 05期
关键词
chemopreventive; polyphenolic; anthocyanins; luteolin; ellagic; punicic; NF-KAPPA-B; ERBB SIGNALING NETWORK; PUNICA-GRANATUM; PROSTATE-CANCER; CELL-LINES; PHASE-II; APOPTOSIS; THERAPY; PATHWAY; PROLIFERATION;
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Breast cancer is the most common malignancy of women in the United States, and the second leading cause of cancer-related death in women. There is a major need for less toxic but yet effective therapies to treat breast cancer. Pomegranate fruit from the tree Punica granatum has been used for centuries for medicinal purposes and is described as "nature's power fruit". The unique biochemical composition of pomegranate fruit being rich in antioxidant tannins and flavonoids has recently drawn attention of investigators to study its anti-cancer effects. Recent research has demonstrated that pomegranate extracts suppress proliferation of breast, prostate, colon and lung cancer cells in vitro and inhibit the growth of breast, prostate, colon and lung tumors in vivo. This review focuses on recent investigations into the effects of pomegranate and its components on cell and molecular mechanisms involved in breast cancer progression.
引用
收藏
页码:58 / 61
页数:4
相关论文
共 55 条
[11]   Signaling to NF-κB [J].
Hayden, MS ;
Ghosh, S .
GENES & DEVELOPMENT, 2004, 18 (18) :2195-2224
[12]   Evolution of juice anthocyanins during ripening of new selected pomegranate (Punica granatum) clones [J].
Hernández, F ;
Melgarejo, P ;
Tomás-Barberán, FA ;
Artés, F .
EUROPEAN FOOD RESEARCH AND TECHNOLOGY, 1999, 210 (01) :39-42
[13]   Functional interference of Sp1 and NF-κB through the same DNA binding site [J].
Hirano, F ;
Tanaka, H ;
Hirano, Y ;
Hiramoto, M ;
Handa, H ;
Makino, I ;
Scheidereit, C .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (03) :1266-1274
[14]   Drug therapy: Trastuzumab - Mechanism of action and use in clinical practice [J].
Hudis, Clifford A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (01) :39-51
[15]  
Joe AK, 2002, CLIN CANCER RES, V8, P893
[16]   NF-κB and breast cancer [J].
Johnstone, PAS ;
Takimoto, CHM ;
Goulet, R .
CURRENT PROBLEMS IN CANCER, 2002, 26 (05) :282-309
[17]   Tamoxifen (ICI46,474) as a targeted therapy to treat and prevent breast cancer [J].
Jordan, VC .
BRITISH JOURNAL OF PHARMACOLOGY, 2006, 147 :S269-S276
[18]   Inhibition of NFκB and Pancreatic Cancer Cell and Tumor Growth by Curcumin Is Dependent on Specificity Protein Down-regulation [J].
Jutooru, Indira ;
Chadalapaka, Gayathri ;
Lei, Ping ;
Safe, Stephen .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (33) :25332-25344
[19]   Nuclear factor-κB in cancer development and progression [J].
Karin, Michael .
NATURE, 2006, 441 (7092) :431-436
[20]  
Kerr WG, 2011, ANN NY ACAD SCI, V1217, P1